Alparslan Kurtul

Publications (5)3.54 Total impact

• Article: Acute coronary syndrome with intraventricular thrombus after using erythropoietin.

  Alparslan Kurtul, Mustafa Duran, Onur Kadir Uysal, Ender Ornek
  Anadolu kardiyoloji dergisi: AKD = the Anatolian journal of cardiology 02/2013; · 0.44 Impact Factor
• Article: Diphtheria myocarditis in Turkey after years.

  Ender Ornek, Cağin Mustafa Ureyen, Alparslan Kurtul, Fatih Oksüz
  Anadolu kardiyoloji dergisi: AKD = the Anatolian journal of cardiology 03/2012; 12(3):279-80. · 0.44 Impact Factor
• Article: Coronary stenting for acute myocardial infarction in a patient with an anomalous origin of the left main coronary artery.

  Mustafa Duran, Ender Ornek, Sani Namk Murat, Bora Demircelik, Mehmet Akif Vatankulu, Murat Turfan, Alparslan Kurtul
  [show abstract] [hide abstract]
  ABSTRACT: The angiographical incidence of coronary anomalies was 1.3%. Anomalous origin of the left main coronary artery arising from the right sinus of Valsalva is extremely rare occurring in approximately 0.019% of angiographic series. Most of these anomalies are not clinically important. Percutaneous coronary intervention plays an important role in the management of acute myocardial infarction, and coronary anomalies may determine a lower success rate of this intervention. We report here the unusual case of a patient with single coronary ostium and acute inferior myocardial infarction who underwent successful coronary stenting.
  Journal of Cardiovascular Medicine 03/2011; 12(6):436-8. · 1.51 Impact Factor
• Article: Letter: comment on: The influence of left ventricular diameter on left atrial appendage size and thrombus formation in patients with dilated cardiomyopathy.

  Ender Ornek, Alparslan Kurtul, Mustafa Duran, M Bora Demirçelik
  Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir 01/2011; 39(1):90; author reply 90-1.
• Source

  Available from: Mustafa Duran

  Article: The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction.

  Ender Ornek, Sani Murat, Mustafa Duran, Murat Turfan, Alparslan Kurtul, Muhammed B Demircelik, Mehmet A Vatankulu, Hakan Ocek, Ramazan Akdemir
  [show abstract] [hide abstract]
  ABSTRACT: The present study aimed to investigate the relationship between the severity of coronary artery disease (CAD) and level of Lipoprotein (LP)(a). The study included 52 CAD patients and a control group consisting of 38 individuals. The patients were classified into three groups based on the clinical form of CAD (stable angina pectoris, SAP, unstable angina pectoris, UAP, and myocardial infarction,MI), and were further divided into three groups based on CAD severity (1-, 2- and 3-vessel). Serum Lp(a) levels were monitored 4, 8, and 24 h, 10 and 30 days following acute MI in 18 patients. Based on regression analysis, Lp(a) was not correlated with other lipoproteins or with risk factors of CAD, such as body mass index, smoking, family history, diabetes, age, gender, and hypertension (r = 0.08-0.22). 72% of the patients in the CAD group and 24% of the control group had an Lp(a) level > 30 mg dL(-1) (P = 0.004), and Lp(a) levels were higher in 3-vessel patients than in 2-vessel and 1-vessel CAD patients (86% vs. 68%, P = 0.02 and 86% vs. 62%, P=0.01, respectively). Serum Lp(a) levels were higher in the UAP and MI groups than in the SAP group (48 ± 44.7 mg dL(-1), 49 ± 36.1 mg dL(-1) and 31.2 ± 22.3 mg dL(-1), respectively, P=0.02). Lp(a) levels increased after acute MI, and reached peak levels 10 days post-MI (41% increase, P=0.001) and remained considerably elevated (18%) 30 days post-MI (P=0.01). Serum Lp(a) was higher in the UAP and MI patients in comparison with the SAP patients, and was higher in 3-vessel CAD in comparison with 1- and 2-vessel CAD patients.
  Clinical and investigative medicine. Medecine clinique et experimentale 01/2011; 34(1):E14-20. · 1.15 Impact Factor